Company profile: SolveBio
1.1 - Company Overview
Company description
- Provider of a Genomic Intelligence Platform and on-demand expertise that monitors, gathers, and secures genomic data to drive precision medicine, serving pharma, biotech, and diagnostic organizations with a contextual knowledge hub to connect and use external and internal genomic information.
Products and services
- Contextual Knowledge Hub: A contextual hub that delivers pharma, biotech, and diagnostic organizations the ability to connect and use external and internal genomic information for precision medicine
- Genomic Intelligence Platform: A secure platform engineered to monitor, gather, and secure genomic data for precision medicine applications, supporting ongoing tracking of genomic intelligence
- On-demand Genomic Expertise: On-demand expertise that supplies precision medicine teams guidance to monitor, gather, and secure Genomic Intelligence while connecting internal and external genomic information
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SolveBio
Krystal Biotech
HQ: United States
Website
- Description: Provider of gene therapies, including FDA-approved VYJUVEK for delivering missing or defective genes to the skin; with focus on Autosomal Recessive Congenital Ichthyosis, Netherton Syndrome, Cystic Fibrosis, and Alpha-1 Antitrypsin Deficiency; and oncology development using a modified HSV-1 vector to deliver IL-12 and IL-2 to the tumor microenvironment for immune-mediated tumor clearance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Krystal Biotech company profile →
OncoDNA
HQ: Belgium
Website
- Description: Provider of precision medicine for cancer treatment, leveraging over 60 years’ expertise in medical diagnostics and extensive experience in DNA sequencing and diagnostic analyses in oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoDNA company profile →
KSQ Therapeutics
HQ: United States
Website
- Description: Provider of CRISPR-enabled drug discovery and development, offering KSQ-4279, a USP1 inhibitor in Phase 1 for advanced solid tumors targeting DNA damage repair; eTIL autologous cell therapies (KSQ-001, KSQ-004) engineered for enhanced tumor killing in solid tumors; the CRISPRomics platform for target identification in oncology and autoimmune diseases; CRISPR2 guide-pairing technology; and the ExPRESS process for eTIL manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KSQ Therapeutics company profile →
Smart Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical drug discovery and development focused on orally administered drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Smart Therapeutics company profile →
Genetron Health
HQ: China
Website
- Description: Provider of precision medicine solutions: cancer diagnostics and monitoring via genetic mutation detection to guide treatment and track disease; early cancer screening using cfDNA and protein markers, focused on liver cancer; biopharma development services for trial design, companion diagnostics, and target screening; and the GENETRON 3D Biochip Reader, a digital PCR platform for liquid biopsy and genetic testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genetron Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SolveBio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SolveBio
2.2 - Growth funds investing in similar companies to SolveBio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SolveBio
4.2 - Public trading comparable groups for SolveBio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →